Variability of multi-omics profiles in a population-based child cohort

Archive ouverte

Gallego-Paüls, Marta | Hernández-Ferrer, Carles | Bustamante, Mariona | Basagaña, Xavier | Barrera-Gómez, Jose | Lau, Chung-Ho E | Siskos, Alexandros, P | Vives-Usano, Marta | Ruiz-Arenas, Carlos | Wright, John | Slama, Remy | Heude, Barbara | Casas, Maribel | Grazuleviciene, Regina | Chatzi, Leda | Borràs, Eva | Sabidó, Eduard | Carracedo, Ángel | Estivill, Xavier | Urquiza, Jose | Coen, Muireann | Keun, Hector, C | González, Juan, R | Vrijheid, Martine | Maitre, Léa

Edité par CCSD ; BioMed Central -

International audience. Background: Multiple omics technologies are increasingly applied to detect early, subtle molecular responses to environmental stressors for future disease risk prevention. However, there is an urgent need for further evaluation of stability and variability of omics profiles in healthy individuals, especially during childhood. Methods: We aimed to estimate intra-, inter-individual and cohort variability of multi-omics profiles (blood DNA methylation, gene expression, miRNA, proteins and serum and urine metabolites) measured 6 months apart in 156 healthy children from five European countries. We further performed a multi-omics network analysis to establish clusters of co-varying omics features and assessed the contribution of key variables (including biological traits and sample collection parameters) to omics variability. Results: All omics displayed a large range of intra-and inter-individual variability depending on each omics feature, although all presented a highest median intra-individual variability. DNA methylation was the most stable profile (median 37.6% inter-individual variability) while gene expression was the least stable (6.6%). Among the least stable features, we identified 1% cross-omics co-variation between CpGs and metabolites (e.g. glucose and CpGs related to obesity and type 2 diabetes). Explanatory variables, including age and body mass index (BMI), explained up to 9% of serum metabolite variability. Conclusions: Methylation and targeted serum metabolomics are the most reliable omics to implement in single time-point measurements in large cross-sectional studies. In the case of metabolomics, sample collection and individual traits (e.g. BMI) are important parameters to control for improved comparability, at the study design or analysis stage. This study will be valuable for the design and interpretation of epidemiological studies that aim to link omics signatures to disease, environmental exposures, or both.

Suggestions

Du même auteur

Multi-omics signatures of the human early life exposome

Archive ouverte | Maitre, Léa | CCSD

International audience. Abstract Environmental exposures during early life play a critical role in life-course health, yet the molecular phenotypes underlying environmental effects on health are poorly understood. I...

In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children

Archive ouverte | Vives-Usano, Marta | CCSD

International audience. BackgroundThe adverse health effects of early life exposure to tobacco smoking have been widely reported. In spite of this, the underlying molecular mechanisms of in utero and postnatal expos...

Machine learning-based health environmental-clinical risk scores in European children

Archive ouverte | Guimbaud, Jean-Baptiste | CCSD

International audience. Background Early life environmental stressors play an important role in the development of multiple chronic disorders. Previous studies that used environmental risk scores (ERS) to assess the...

Chargement des enrichissements...